The mRNA Vaccines and Therapeutics Market is estimated at $3.43 billion in 2018. The Standardized Therapeutic Cancer mRNA Vaccines segment held a share of 35.47% in 2018 and is projected to grow with a CAGR of 9.77% in next ten years.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 184-page report you will receive 130 charts– all unavailable elsewhere.
The 184-page report provides clear detailed insight into the mRNA Vaccines and Therapeutics Market. Discover the key drivers and challenges affecting the market.
Report Scope
• Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market
• Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market by type: • Standardized Therapeutic Cancer mRNA Vaccines • Individualized Therapeutic Cancer mRNA Vaccines • Therapeutic Infectious Disease mRNA Vaccines • mRNA Therapeutic for Other Diseases
• Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market by Mechanism of Action: • Bioengineered Vaccine • Gene Therapy (Gene Silencing/Suppression) • Gene Transcription (Protein Generation) • Cell Therapy • Monoclonal Antibody • Others
• Revenue and growth forecasts from 2019 to 2029 for the leading regional and national markets: • North America: the revenues are further broken down into the US and Canada • Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain • Asia-Pacific: the revenues are further broken down into China, Japan and India • Rest of the World: the revenues are further broken down into Brazil, Mexico, Russia and South Africa
• Discussion and profiles of the leading players in the mRNA Vaccines and Therapeutics market: • Argos Therapeutics, Inc. • BioNTech AG • CureVac AG • eTheRNA Immunotherapies • ethris GmbH • In-Cell-Art • Moderna Therapeutics • Sangamo Therapeutics, Inc. • Tiba Biotech • Translate Bio, Inc.
• Qualitative analysis of factors that drive and restrain the mRNA Vaccines and Therapeutics market. Trends analysis of the mRNA Vaccines and Therapeutics market.
• mRNA Vaccines and Therapeutics R&D pipeline analysis
• Key Questions Answered by this Report: • How is the mRNA vaccines and therapeutics market evolving? • What is driving and restraining the mRNA vaccines and therapeutics market? • What are the market shares of the leading segments of the mRNA vaccines and therapeutics market in 2018? • What will be the main driver of the overall market from 2019 to 2029? • How will the market shares of the leading national markets change by 2029 and which country will lead the market in 2029? • How will the industry evolve during the period between 2019 and 2029? • Who are the leading companies in this market?
Visiongain’s study is intended for anyone requiring commercial analyses for the mRNA Vaccines and Therapeutics market. You find data, trends and predictions.
Buy our report today mRNA Vaccines and Therapeutics Market : Standardized Therapeutic Cancer mRNA Vaccines, Individualized Therapeutic Cancer mRNA Vaccines, Therapeutic Infectious Disease mRNA Vaccines, mRNA Therapeutic for Other Diseases, Bioengineered Vaccine, Gene Transcription, Monoclonal Antibody, Gene Therapy, Cell Therapy.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview
1.1 Global mRNA Vaccines and Therapeutics Market Overview
1.2 Global mRNA Vaccines and Therapeutics Market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Main Questions Answered by this Report
1.8 Who is this Report for?
1.9 Research and Analysis Methods
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Reports
1.12 About Visiongain
2. Introduction to mRNA Vaccines and Therapeutics
2.1 History of mRNA Vaccines & Therapeutics Development
2.2 Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases
2.3 Prevention and Treatment Using mRNA Vaccines & Therapeutics
2.3.1 mRNA Modifications
2.3.2 mRNA Efficiencies
2.3.3 Adjuvant/Stimulant & Carrier Technologies for mRNA-based Vaccines
2.3.4 Carriers for mRNA-based Protein & Antibody Therapeutics
3. Introduction of mRNA & Delivery Technologies
3.1 Ex vivo mRNA Loading
3.1.1 Arcelis Technology
3.1.2 Flow Electroporation Technology
3.2 In vivo Carrier & mRNA
3.2.1 Hybrid mRNA Technology
3.2.2 Lipid Nanoparticle (LNP) mRNA Technology
3.2.3 Nanotaxi Technology
3.2.4 RNArt & RNAntibody Technology
3.2.5 UNA & LUNAR Technologies
3.3 mRNA Vaccines & Stimulants / Adjuvants
3.3.1 RNActive Technology
3.3.2 Self-Amplifying mRNA (SAM) Technology
3.3.3 TriMix Technology
4. Global mRNA Vaccines & Therapeutics: Market Size and Forecast 2019-2029
4.1 mRNA Vaccines and Therapeutics Market Overview, 2018
4.2 The World mRNA Vaccines and Therapeutics Market
4.3 World mRNA Vaccines and Therapeutics Market: Sales Forecast 2019-2029
4.4 Changing Market Shares by Region 2018-2029
5. mRNA Vaccines and Therapeutics Market: Drivers, Restraints, and Trends Analysis 2019-2029
5.1 mRNA Vaccines and Therapeutics Market: Drivers 2019-2029
5.1.1 Rising Adoption of Personalized Medicine for Effective Treatment
5.1.2 Advantages Offered by mRNA-based Products
5.1.3 Rising Funding by Pharmaceutical Companies and Government Organizations
5.2 mRNA Vaccines and Therapeutics Market: Restraints 2019-2029
5.2.1 Delivery of mRNA therapeutics and vaccines
5.2.2 Stringent Government Regulations for mRNA-based Product Approvals
5.3 mRNA Vaccines and Therapeutics Market: Trends 2019-2029
5.3.1 Rising adoption of gene therapy-based products
6. mRNA Vaccines & Therapeutics by Type: Market Size and Forecast 2019-2029
6.1 Market Forecast 2019-2029
6.2 Market Share of mRNA Vaccines and Therapeutics by Type
6.2.1 Standardized Therapeutic Cancer mRNA Vaccines: Market Forecast, 2019-2029
6.2.2 Individualized Therapeutic Cancer mRNA Vaccines: Market Forecast, 2019-2029
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.
Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.
Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031
Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
